Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Healthcare Drug Manufacturers - Major
Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

Elixxer Ltd.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by ImperialCreditson Feb 02, 2018 9:07am
28 Views
Post# 27487460

RE:RE:RE:RE:LGC

RE:RE:RE:RE:LGCI’ve received emails that confirm DuckDive is under formal investigation by the OSC.


Treydardon wrote:
Ducky has been a good investor lately ahah. Don't drag him back into his old habits lol. Good luck today everyone. Hopefully ducky scooped up the shares he needed and can provide some relevant news to the board.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities